tiprankstipranks
Advertisement
Advertisement
MapLight Therapeutics initiated with a Buy at Craig-Hallum
PremiumThe FlyMapLight Therapeutics initiated with a Buy at Craig-Hallum
23d ago
Analyst Reiterates Buy on MapLight, Maintains $37 Price Target on Confidence in ML-007 and Pipeline Upside
Premium
Ratings
Analyst Reiterates Buy on MapLight, Maintains $37 Price Target on Confidence in ML-007 and Pipeline Upside
24d ago
Buy Rating Reiterated on Clinical Catalysts and Strong Cash Runway; $37 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on Clinical Catalysts and Strong Cash Runway; $37 Price Target Unchanged
29d ago
MapLight Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyMapLight Therapeutics initiated with a Buy at H.C. Wainwright
1M ago
MapLight Therapeutics completes enrollment in ZEPHYR trial
Premium
The Fly
MapLight Therapeutics completes enrollment in ZEPHYR trial
1M ago
MapLight Therapeutics Announces Board Refresh and New Nominees
Premium
Company Announcements
MapLight Therapeutics Announces Board Refresh and New Nominees
1M ago
Canaccord starts MapLight with Buy into schizophrenia data
PremiumThe FlyCanaccord starts MapLight with Buy into schizophrenia data
3M ago
MapLight Therapeutics initiated with a Buy at Canaccord
Premium
The Fly
MapLight Therapeutics initiated with a Buy at Canaccord
3M ago
MapLight updates trial timelines and highlights CNS pipeline
Premium
Company Announcements
MapLight updates trial timelines and highlights CNS pipeline
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100